Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avita Medical, Inc. - Common Stock (NQ: RCEL )

9.320 +0.370 (+4.13%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 Next >
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Third Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Third Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Second Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
From AVITA Medical
Via GlobeNewswire
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
Exclusive development and distribution agreement with Regenity Biosciences provides AVITA Medical with the commercialization rights to a unique collagen-based dermal matrix following 510(k) clearance 
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Second Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
Donna Shiroma retires after distinguished service as General Counsel 
From AVITA Medical
Via GlobeNewswire
AVITA Medical Achieves Milestone with First Case Using RECELL GO
Joseph M. Still Burn Center at Doctors Hospital of Augusta first to treat a patient using AVITA Medical’s FDA-Approved RECELL GO System for thermal burn wounds and full-thickness skin defects 
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces FDA Approval of RECELL GO
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports First Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce First Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Updates Expected First Quarter 2024 Revenue
From AVITA Medical
Via GlobeNewswire
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
From AVITA Medical
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.